Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock. Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.